Clinical Trials in Los Angeles

Showing 1681-1700 of 8,055 trials

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

NCT05406583

This study will test an anti-HIV drug (ARV) for newborn babies. The study will include a minimum of 36 and up to 108 mothers living with HIV and their newborn babies from Brazil, South Africa, Thailand, and the United States. Infants will be in the study for approximately 16 weeks (four months) after they are born. Mothers will not receive study drug and will exit the study after the Entry visit.

HIV

National Institute of Allergy and Infectious Diseases (NIAID)48 participantsStarted Oct 2022

Los Angeles, California, United States • Los Angeles, California, United States • Aurora, Colorado, United States +12 more locations

COMPLETEDPhase 2< 1 mile

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

NCT01065454

The aim of this study is to assess whether increasing oral doses of Riociguat are safe and improve the well-being, symptoms and outcome in patients with pulmonary hypertension associated with left ventricular systolic dysfunction

Hypertension, PulmonaryVentricular Dysfunction, Left

Bayer202 participantsStarted Apr 2010

Los Angeles, California, United States • San Diego, California, United States • Torrance, California, United States +80 more locations

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

Find Trials by Condition in Los Angeles

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines

A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

A Study of LY3549492 in Healthy Weight Adult Participants

Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir

Validation of Perin Health Patch ECG Monitoring Device Performance and Placement Accuracy

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia